Paper26344763
Endogenous Sterol Metabolites Regulate Growth of EGFR/KRAS-Dependent Tumors via LXR.
Gabitova L and 12 others. Cell Rep, 2015. Cited by 76 papers, by iCite.
Cite this record
ConductScience Library. Endogenous Sterol Metabolites Regulate Growth of EGFR/KRAS-Dependent Tumors via LXR. Papers, record 26344763. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26344763
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cholesterol | Major topic |
| ErbB Receptors | Major topic |
| Proto-Oncogene Proteins p21(ras) | Major topic |
| Sterols | Major topic |
| 3-Hydroxysteroid Dehydrogenases | |
| Animals | |
| Cell Line, Tumor | |
| Female | |
| Humans | |
| Liver X Receptors | |
| Male | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Knockout | |
| Orphan Nuclear Receptors | |
| Papilloma | |
| Signal Transduction | |
| Skin Neoplasms | |
| Transfection |
Source PubMed
Grants12
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R21 CA164205 | NCI NIH HHS | United States | R21CA164205 | PubMed and NIH | NIH RePORTER |
| R01 CA63366 | NCI NIH HHS | United States | R01CA063366 | PubMed and NIH | NIH RePORTER |
| R01 CA188430 | NCI NIH HHS | United States | R01CA188430 | PubMed and NIH | NIH RePORTER |
| R01 HD38572 | NICHD NIH HHS | United States | R01HD038572 | PubMed and NIH | NIH RePORTER |
| K22 CA160725 | NCI NIH HHS | United States | K22CA160725 | PubMed and NIH | NIH RePORTER |
| R01 HD038572 | NICHD NIH HHS | United States | R01HD038572 | PubMed and NIH | NIH RePORTER |
| R01 CA063366 | NCI NIH HHS | United States | R01CA063366 | PubMed and NIH | NIH RePORTER |
| R01 CA080991 | NCI NIH HHS | United States | R01CA080991 | PubMed and NIH | NIH RePORTER |
| R01 CA113342 | NCI NIH HHS | United States | R01CA113342 | PubMed and NIH | NIH RePORTER |
| P30 CA006927 | NCI NIH HHS | United States | P01CA006927 | PubMed and NIH | NIH RePORTER |
| CA-06927 | NCI NIH HHS | United States | P01CA006927 | PubMed and NIH | NIH RePORTER |
| P30CA006927 | NIH | NIH RePORTER |
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19309000 | Targeted disruption of Bcl-xL in mouse keratinocytes inhibits both UVB- and chemically induced skin carcinogenesis. | Mol Carcinog | 2009 | https://conductscience.org/library/papers/19309000 | PubMed |
| 2 | 24581497 | Broad-spectrum therapeutic suppression of metastatic melanoma through nuclear hormone receptor activation. | Cell | 2014 | https://conductscience.org/library/papers/24581497 | PubMed |
| 3 | 20037595 | Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses. | Nat Med | 2010 | https://conductscience.org/library/papers/20037595 | PubMed |
| 4 | 20048381 | Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters. | J Lipid Res | 2010 | https://conductscience.org/library/papers/20048381 | PubMed |
| 5 | 20360469 | Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma. | Blood | 2010 | https://conductscience.org/library/papers/20360469 | PubMed |
| 6 | 20488992 | ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. | Science | 2010 | https://conductscience.org/library/papers/20488992 | PubMed |
| 7 | 20696928 | Dysregulation of the mevalonate pathway promotes transformation. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20696928 | PubMed |
| 8 | 23558541 | Steroidal triterpenes of cholesterol synthesis. | Molecules | 2013 | https://conductscience.org/library/papers/23558541 | PubMed |
| 9 | 23125191 | Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation. | Cancer Discov | 2013 | https://conductscience.org/library/papers/23125191 | PubMed |
| 10 | 24675946 | Cancer. Cholesterol and cancer, in the balance. | Science | 2014 | https://conductscience.org/library/papers/24675946 | PubMed |
| 11 | 25651181 | Identification of natural RORγ ligands that regulate the development of lymphoid cells. | Cell Metab | 2015 | https://conductscience.org/library/papers/25651181 | PubMed |
| 12 | 25652406 | Analysis of hedgehog signaling in cerebellar granule cell precursors in a conditional Nsdhl allele demonstrates an essential role for cholesterol in postnatal CNS development. | Hum Mol Genet | 2015 | https://conductscience.org/library/papers/25652406 | PubMed |
| 13 | 22059152 | An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway. | Cancer Discov | 2011 | https://conductscience.org/library/papers/22059152 | PubMed |
| 14 | 11035776 | Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/11035776 | PubMed |
| 15 | 11172721 | A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. | Mol Cell | 2001 | https://conductscience.org/library/papers/11172721 | PubMed |
| 16 | 11751630 | Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. | Genes Dev | 2001 | https://conductscience.org/library/papers/11751630 | PubMed |
| 17 | 12966526 | Left-sided CHILD syndrome caused by a nonsense mutation in the NSDHL gene. | Am J Med Genet A | 2003 | https://conductscience.org/library/papers/12966526 | PubMed |
| 18 | 14622593 | Lipid rafts: elusive or illusive? | Cell | 2003 | https://conductscience.org/library/papers/14622593 | PubMed |
| 19 | 14726596 | EGF-like growth factors as mediators of LH action in the ovulatory follicle. | Science | 2004 | https://conductscience.org/library/papers/14726596 | PubMed |
| 20 | 15093544 | Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. | Cancer Cell | 2004 | https://conductscience.org/library/papers/15093544 | PubMed |
Cited by55
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41952197 | NSDHL as a regulator of lipid peroxidation and ER stress-mediated apoptosis in ovarian cancer. | Biol Direct | 2026 | https://conductscience.org/library/papers/41952197 | PubMed |
| 41845506 | METTL16-mediated m6A modification of MSMO1 modulates cholesterol metabolism and activates MAPK-p38/NF-κB signaling in colorectal cancer. | J Exp Clin Cancer Res | 2026 | https://conductscience.org/library/papers/41845506 | PubMed |
| 41782822 | MSMO1 promotes chemotherapy resistance through modulation of T-MAS metabolism via PERK/elF2α/ATF4/CHOP pathway. | iScience | 2026 | https://conductscience.org/library/papers/41782822 | PubMed |
| 41437393 | USP43 promotes gemcitabine resistance by regulating cholesterol homeostasis through E2F1 stabilization in bladder cancer. | J Exp Clin Cancer Res | 2025 | https://conductscience.org/library/papers/41437393 | PubMed |
| 41312741 | Liver X receptor: A potential target for inflammatory bowel disease and colorectal cancer (Review). | Mol Med Rep | 2026 | https://conductscience.org/library/papers/41312741 | PubMed |
| 40033501 | Integrated Bioinformatics Analysis Revealing that the NSDHL Gene Might Be Associated with the Progression of Western HFD/SW-Induced Hepatocellular Carcinoma | Endocr Metab Immune Disord Drug Targets | 2026 | https://conductscience.org/library/papers/40033501 | PubMed |
| 38896016 | The role of ATP-binding cassette subfamily G member 1 in tumor progression. | Cancer Med | 2024 | https://conductscience.org/library/papers/38896016 | PubMed |
| 38488003 | The cholesterol biosynthesis enzyme FAXDC2 couples Wnt/β-catenin to RTK/MAPK signaling. | J Clin Invest | 2024 | https://conductscience.org/library/papers/38488003 | PubMed |
| 37481560 | Melanoma cells induce dedifferentiation and metabolic changes in adipocytes present in the tumor niche. | Cell Mol Biol Lett | 2023 | https://conductscience.org/library/papers/37481560 | PubMed |
| 37441160 | IVM of human immature oocytes for infertility treatment and fertility preservation. | Reprod Med Biol | 2023 | https://conductscience.org/library/papers/37441160 | PubMed |
| 37059993 | Claudin-4-adhesion signaling drives breast cancer metabolism and progression via liver X receptor β. | Breast Cancer Res | 2023 | https://conductscience.org/library/papers/37059993 | PubMed |
| 37022791 | Glioblastomas: Hijacking Metabolism to Build a Flexible Shield for Therapy Resistance. | Antioxid Redox Signal | 2023 | https://conductscience.org/library/papers/37022791 | PubMed |
| 36841765 | Prognosis-related molecular subtyping in head and neck squamous cell carcinoma patients based on glycolytic/cholesterogenic gene data. | Cancer Cell Int | 2023 | https://conductscience.org/library/papers/36841765 | PubMed |
| 36672209 | ABCA1-Mediated EMT Promotes Papillary Thyroid Cancer Malignancy through the ERK/Fra-1/ZEB1 Pathway. | Cells | 2023 | https://conductscience.org/library/papers/36672209 | PubMed |
| 36459180 | Development of SOS1 Inhibitor-Based Degraders to Target KRAS-Mutant Colorectal Cancer. | J Med Chem | 2022 | https://conductscience.org/library/papers/36459180 | PubMed |
| 36381317 | CPSF1 positively regulates NSDHL by alternative polyadenylation and promotes gastric cancer progression. | Am J Cancer Res | 2022 | https://conductscience.org/library/papers/36381317 | PubMed |
| 35924232 | A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes. | Front Immunol | 2022 | https://conductscience.org/library/papers/35924232 | PubMed |
| 35790992 | Lipid metabolism in tumor microenvironment: novel therapeutic targets. | Cancer Cell Int | 2022 | https://conductscience.org/library/papers/35790992 | PubMed |
| 35719918 | Cholesterol and Its Derivatives: Multifaceted Players in Breast Cancer Progression. | Front Oncol | 2022 | https://conductscience.org/library/papers/35719918 | PubMed |
| 35050168 | Ubiquitous Aberration in Cholesterol Metabolism across Pancreatic Ductal Adenocarcinoma. | Metabolites | 2022 | https://conductscience.org/library/papers/35050168 | PubMed |
Genes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26344763
GET https://conductscience.org/api/papers/v1/26344763/references?page=2